GLP-1 medications have a well-established side effect profile. Most side effects are GI-related, tend to peak during dose escalation, and improve over time for most patients. A small percentage of patients experience side effects serious enough to discontinue. This guide covers everything you should know before starting.
Common Side Effects (Affect Most Patients)
These side effects are common enough that you should expect at least some of them, especially early in treatment:
- Nausea: The most common side effect. Affects 40–50% of patients, especially in the first few weeks and after dose increases. Usually improves within 2–4 weeks at a stable dose.
- Decreased appetite: Technically the intended effect, but can feel extreme for some patients, especially early on when caloric intake drops sharply.
- Constipation: Affects about 25–35% of patients. GLP-1 medications slow gut motility. Staying hydrated and maintaining fiber intake helps significantly.
- Diarrhea: Less common than constipation but affects some patients, particularly early in treatment.
- Vomiting: More common at higher doses. Typically signals that dose escalation is moving too fast.
- Fatigue: Especially in the first few weeks. Often related to reduced caloric intake.
- Injection site reactions: Redness, swelling, or mild pain at the injection site. Usually minor and transient.
Managing the GI Side Effects
Most GI side effects can be significantly reduced with simple strategies:
- Eat smaller, more frequent meals rather than large ones
- Avoid high-fat or very spicy foods, especially early in treatment
- Eat slowly and stop before you feel full
- Stay well hydrated
- Don't skip the dose escalation schedule, going up too fast dramatically increases side effects
- Take your injection in the evening if morning nausea is a problem
Less Common but Important Side Effects
Gastroparesis-like symptoms: GLP-1 medications slow gastric emptying, which in some patients can become clinically significant. Persistent nausea, vomiting, and a feeling of fullness long after eating may indicate gastric emptying has slowed more than intended. This requires medical evaluation.
Gallbladder problems: Rapid weight loss of any kind, not unique to GLP-1 medications, can increase the risk of gallstones. The STEP trials showed a modestly increased rate of gallbladder events. Patients with prior gallbladder issues should discuss this with their physician.
Muscle loss: A significant portion of weight lost on GLP-1 medications is lean mass, not just fat. Adequate protein intake (0.7–1g per pound of goal body weight) and resistance training help preserve muscle during weight loss.
Hair loss (telogen effluvium): Rapid weight loss can trigger a form of temporary hair shedding. This is not unique to GLP-1 medications, it's a response to the metabolic stress of rapid weight reduction. Hair typically grows back.
Serious but Rare Side Effects
GLP-1 medications carry a black box warning for medullary thyroid carcinoma (MTC). In animal studies, GLP-1 receptor agonists caused thyroid tumors. This risk hasn't been established in humans, but these medications are contraindicated for anyone with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2.
Pancreatitis has been reported with GLP-1 medications, though causality isn't firmly established. Symptoms include severe abdominal pain radiating to the back, nausea, and vomiting. Seek medical attention immediately if these occur.
Who Should Not Take GLP-1 Medications
- Personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Prior serious hypersensitivity reaction to semaglutide or tirzepatide
- Pregnancy or planning to become pregnant (discontinue 2 months before planned pregnancy)
- Pancreatitis history (relative contraindication, discuss with physician)